Bharat Biotech’s Covaxin receives approval for Phase III trials: Reports
By Administrator_India
Bharat Biotech’s coronavirus vaccine Covaxin has received approval for carrying out Phase III trials on October 22, reports suggest.
The approvals were reportedly given after assessing data from Phase I and II and animal challenge study.
Phase III is likely to start next month, Business Today reported. The report said an expert committee met on October 20 to give its nod to Phase III trials and suggested some ‘minor amendments’ in the protocol.
